IL1B and inflammatory bowel disease: Additional regulators—such as anti-neutrophil cytoplasmic antibodies (ANCA) and IL-1β—modulate NET abundance in IBD, underscoring multifaceted contributions of NETs to mucosal injury and disease progression [151].